Plain-English translation of NCT07288970 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing two different approaches to pain control during and after knee replacement surgery, both using nerve blocks—numbing injections that target specific nerves around the knee. Both approaches combine the same foundational nerve block (adductor canal block) with one of two additional techniques: either a sacral erector spinae plane block or an iPACK block. The goal is to figure out which combination works better at keeping patients comfortable after surgery while preserving their ability to move and strengthen their leg.
Knee replacement surgery can cause significant pain after the operation, which can slow down recovery, delay rehabilitation, and sometimes lead to increased use of opioid pain medications. Doctors want to find the most effective nerve-blocking strategy that provides excellent pain relief while minimizing side effects and keeping patients' leg strength intact.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will be randomly assigned to receive one of the two nerve block combinations during your knee replacement surgery—both performed by an anesthesiologist using ultrasound guidance. After surgery, you will be monitored for pain and other symptoms, and researchers will record when you first ask for additional pain medication, your pain levels at rest and during movement, how much opioid medication you use, and how well your leg strength recovers. The study follows you for at least 48 hours after surgery as part of your normal hospital stay and recovery process.
AI-generated summary from trial data · Jun 15, 2026 · Not medical advice
Poland